Stocks To Buy Now

Blog


Investor Summit Q1 Conference – featuring C Level Management of 65 + Companies

Companies and investors are invited to attend the Q1 2022 Virtual Investor Summit being held as a virtual event on March 8-9th, 2022.  The Investor Summit has been the largest independent conference on the East Coast for many years (formerly “The Microcap Conference”) and represents companies that are looking for a timely platform to connect with investors. The Q1 investor Summit focuses on connecting small and microcap companies with potential investors from large institutions, family businesses, private wealth and money managers. This Q1 conference will offer C level executives the opportunity to make presentations about the state of their business, updates on financials and future goals. Small and microcap companies can connect with investors through one-on-one discussions, presentations, and dialogues. “Our investors and presenting companies return to us repeatedly, owing to the immense response that they receive at these conferences.” Company Benefits 
  • Scheduled meetings with qualified investors (average 8 per)
  • 30-minute webcast with Q&A (average is 30+ attendees)
  • Concierge meeting scheduling
  • Press release distributed to the investor community in advance of the conference
  • Webcast promoted on the conference website for 90 days post-conference
  • Access to 800 registered attendees
  • Media assets for social sharing
  • Personalized tech training sessions
The Q1 Investor Summit 2022 will be organized as a virtual event with webcasts marketed on the website, giving companies optimum exposure. Investors can take part to listen to and meet and get a deep dive into potential stock investments. The seamless user experience offered at the event ensures that small-cap companies connect with investors and build long-term profitable business ties. The event has access to social media sharing, which gives the attending companies greater visibility. Connect with industry leaders and peers for a better knowledge, understanding, and higher ROI for presenting companies. To learn more, please visit https://investorsummitgroup.com/.

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Position in CTCL Treatment with HyBryte(TM) FLASH Results

September 24, 2025

Soligenix (NASDAQ: SNGX) is continuing to build momentum in its mission to advance HyBryte(TM), a first-in-class treatment for early-stage cutaneous T-cell lymphoma (“CTCL”). That progress is supported by results from its pivotal FLASH trial and its ongoing FLASH 2 confirmatory study. Together, the studies highlight not only the efficacy of synthetic hypericin activated by safe […]

Rotate your device 90° to view site.